Natural killer cells in viral hepatitis: Facts and controversies

European Journal of Clinical Investigation

Volumn 40, Issue 9, 2010, Pages 851-863

  Mondelli, Mario U ^a   Varchetta, Stefania ^a   Oliviero, Barbara ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

HBV; HCV; innate immunity; NK cells

Indexed keywords

ALPHA INTERFERON; BETA1 INTEGRIN; BETA2 INTEGRIN; CD56 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA B ANTIGEN; HLA C ANTIGEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR; RIBAVIRIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACUTE HEPATITIS; ANTIGEN EXPRESSION; ANTIVIRAL THERAPY; B LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; FLOW CYTOMETRY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGY; INNATE IMMUNITY; LIVER BIOPSY; LIVER CELL; NATURAL KILLER CELL; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION;

ACUTE DISEASE; ANTIGENS, CD; CYTOKINES; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; KILLER CELLS, NATURAL; LIVER;

EID: 77955464771     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02332.x     Document Type: Review

References (88)

1. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis 2003 23 : 47 58.
2. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int 2009 29 (Suppl. 1 1 8.
3. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science (New York, NY) 1999 284 : 825 829.
4. Cheney IW, Lai VC, Zhong W, Brodhag T, Dempsey S, Lim C et al. Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 2002 76 : 11148 11154.
5. Szabo G, Dolganiuc A. Hepatitis C and innate immunity: recent advances. Clin Liver Dis 2008 12 : 675 692, x.
6. Creagh EM, O'Neill LA. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol 2006 27 : 352 357.
7. Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology 2010 51 : 63 72.
8. Fisicaro P, Valdatta C, Boni C, Massari M, Mori C, Zerbini A et al. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009 58 : 974 982.
9. Wieland SF, Chisari FV. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005 79 : 9369 9380.
10. Cheng G, Zhong J, Chisari FV. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci USA 2006 103 : 8499 8504.
11. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM et al. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci USA 2006 103 : 6001 6006.
12. Foy E, Li K, Wang C, Sumpter R Jr., Ikeda M, Lemon SM et al. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease. Science 2003 300 : 1145 1148.
13. Johnson CL, Owen DM, Gale M Jr. Functional and therapeutic analysis of hepatitis C virus NS3.4A protease control of antiviral immune defense. J Biol Chem 2007 282 : 10792 10803.
14. Stacey AR, Norris PJ, Qin L, Haygreen EA, Taylor E, Heitman J et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J Virol 2009 83 : 3719 3733.
15. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, Liew FY et al. Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002 169 : 4279 4287.
16. Doherty DG, O'Farrelly C. Innate and adaptive lymphoid cells in the human liver. Immunol Rev 2000 174 : 5 20.
17. Gregoire C, Chasson L, Luci C, Tomasello E, Geissmann F, Vivier E et al. The trafficking of natural killer cells. Immunol Rev 2007 220 : 169 182.
18. Chan A, Hong DL, Atzberger A, Kollnberger S, Filer AD, Buckley CD et al. CD56bright human NK cells differentiate into CD56dim cells: role of contact with peripheral fibroblasts. J Immunol 2007 179 : 89 94.
19. Ouyang Q, Baerlocher G, Vulto I, Lansdorp PM. Telomere length in human natural killer cell subsets. Ann N Y Acad Sci 2007 1106 : 240 252.
20. Romagnani C, Juelke K, Falco M, Morandi B, D'Agostino A, Costa R et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007 178 : 4947 4955.
21. Golden-Mason L, Madrigal-Estebas L, McGrath E, Conroy MJ, Ryan EJ, Hegarty JE et al. Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure. Gut 2008 57 : 1121 1128.
22. Lanier LL, Le AM, Civin CI, Loken MR, Phillips JH. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 1986 136 : 4480 4486.
23. Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G et al. CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 2001 31 : 3121 3127.
24. Cooper MA, Fehniger TA, Turner SC, Chen KS, Ghaheri BA, Ghayur T et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset. Blood 2001 97 : 3146 3151.
25. Stegmann KA, Bjorkstrom NK, Veber H, Ciesek S, Riese P, Wiegand J et al. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection. Gastroenterology 2010 138 : 1885 1897.
26. Oliviero B, Varchetta S, Paudice E, Michelone G, Zaramella M, Mavilio D et al. Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections. Gastroenterology 2009 137 : 1151 1160, 60 e1-7.
27. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immun 2008 9 : 495 502.
28. Lanier LL. NK cell recognition. Annu Rev Immunol 2005 23 : 225 274.
29. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009 457 : 557 561.
30. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 285 : 727 729.
31. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 2001 14 : 123 133.
32. Karre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 1986 319 : 675 678.
33. Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 2004 305 : 872 874.
34. de Arias AE, Haworth SE, Belli LS, Burra P, Pinzello G, Vangeli M et al. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation. Liver Transpl 2009 15 : 390 399.
35. Yokoyama WM, Kim S. Licensing of natural killer cells by self-major histocompatibility complex class I. Immunol Rev 2006 214 : 143 154.
36. Orr MT, Murphy WJ, Lanier LL. 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immun 2010 11 : 321 327.
37. Wu J, Song Y, Bakker AB, Bauer S, Spies T, Lanier LL et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999 285 : 730 732.
38. Pende D, Parolini S, Pessino A, Sivori S, Augugliaro R, Morelli L et al. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. J Exp Med 1999 190 : 1505 1516.
39. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, Moretta L et al. Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 1998 188 : 953 960.
40. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, Malaspina A et al. NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 1999 189 : 787 796.
41. Raulet DH. Roles of the NKG2D immunoreceptor and its ligands. Nat Rev 2003 3 : 781 790.
42. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, Bushkin Y et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001 409 : 1055 1060.
43. Ho JW, Hershkovitz O, Peiris M, Zilka A, Bar-Ilan A, Nal B et al. H5-type influenza virus hemagglutinin is functionally recognized by the natural killer-activating receptor NKp44. J Virol 2008 82 : 2028 2032.
44. Arnon TI, Achdout H, Levi O, Markel G, Saleh N, Katz G et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immun 2005 6 : 515 523.
45. Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, Hansen HP et al. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 2007 27 : 965 974.
46. Chemello L, Mondelli M, Bortolotti F, Schiavon E, Pontisso P, Alberti A et al. Natural killer activity in patients with acute viral hepatitis. Clin Exp Immunol 1986 64 : 59 64.
47. Webster GJ, Reignat S, Maini MK, Whalley SA, Ogg GS, King A et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 2000 32 : 1117 1124.
48. Dunn C, Peppa D, Khanna P, Nebbia G, Jones M, Brendish N et al. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009 137 : 1289 1300.
49. Wieland S, Thimme R, Purcell RH, Chisari FV. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 2004 101 : 6669 6674.
50. Rumi MG, De Filippi F, La Vecchia C, Donato MF, Gallus S, Del Ninno E et al. Hepatitis C reactivation in patients with chronic infection with genotypes 1b and 2c: a retrospective cohort study of 206 untreated patients. Gut 2005 54 : 402 406.
51. Amadei B, Urbani S, Cazaly A, Fisicaro P, Zerbini A, Ahmed P et al. Activation of natural killer cells during acute infection with hepatitis C virus. Gastroenterology 2010 138 : 1536 1545.
52. Varchetta S, Oliviero B, Francesca Donato M, Agnelli F, Rigamonti C, Paudice E et al. Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation. J Hepatol 2009 50 : 314 322.
53. Ahlenstiel G, Titerence RH, Koh C, Edlich B, Feld JJ, Rotman Y et al. Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. Gastroenterology 2010 138 : 325 335. e1-2.
54. Duesberg U, Schneiders AM, Flieger D, Inchauspe G, Sauerbruch T, Spengler U. Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C. J Hepatol 2001 35 : 650 657.
55. Morishima C, Paschal DM, Wang CC, Yoshihara CS, Wood BL, Yeo AE et al. Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing. Hepatology 2006 43 : 573 580.
56. De Maria A, Fogli M, Mazza S, Basso M, Picciotto A, Costa P et al. Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients. Eur J Immunol 2007 37 : 445 455.
57. Tseng CT, Klimpel GR. Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions. J Exp Med 2002 195 : 43 9.
58. Crotta S, Stilla A, Wack A, D'Andrea A, Nuti S, D'Oro U et al. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J Exp Med 2002 195 : 35 41.
59. Corado J, Toro F, Rivera H, Bianco NE, Deibis L, De Sanctis JB. Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection. Clin Exp Immunol 1997 109 : 451 457.
60. Nattermann J, Feldmann G, Ahlenstiel G, Langhans B, Sauerbruch T, Spengler U. Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C. Gut 2006 55 : 869 877.
61. Meier UC, Owen RE, Taylor E, Worth A, Naoumov N, Willberg C et al. Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections. J Virol 2005 79 : 12365 12374.
62. Bryceson YT, Fauriat C, Nunes JM, Wood SM, Bjorkstrom NK, Long EO et al. Functional analysis of human NK cells by flow cytometry. Methods Mol Biol 2010 612 : 335 352.
63. Yoon JC, Shiina M, Ahlenstiel G, Rehermann B. Natural killer cell function is intact after direct exposure to infectious hepatitis C virions. Hepatology (Baltimore, Md) 2009 49 : 12 21.
64. Lindenbach BD, Evans MJ, Syder AJ, Wolk B, Tellinghuisen TL, Liu CC et al. Complete replication of hepatitis C virus in cell culture. Science 2005 309 : 623 626.
65. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005 11 : 791 796.
66. Yi M, Villanueva RA, Thomas DL, Wakita T, Lemon SM. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci USA 2006 103 : 2310 2315.
67. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 2005 102 : 9294 9299.
68. Crotta S, Brazzoli M, Piccioli D, Valiante NM, Wack A. Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection. J Hepatol 2010 52 : 183 190.
69. Ju Y, Hou N, Meng J, Wang X, Zhang X, Zhao D et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J Hepatol 2010 52 : 322 329.
70. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001 19 : 65 91.
71. Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci 2008 15 : 137 145.
72. Dunn C, Brunetto M, Reynolds G, Christophides T, Kennedy PT, Lampertico P et al. Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage. J Exp Med 2007 204 : 667 680.
73. Tan AT, Koh S, Goh W, Zhe HY, Gehring AJ, Lim SG et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol 2010 52 : 330 339.
74. Bonorino P, Ramzan M, Camous X, Dufeu-Duchesne T, Thelu MA, Sturm N et al. Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C. J Hepatol 2009 51 : 458 467.
75. Varchetta SOB, Paudice E, Cremonesi E, Michelone G, Zaramella M, Mondelli MU. Defective cytotoxic function of intrahepatic natural killer cells in chronic hepatitis C virus infection. 60th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, USA. Hepatology 2009 50 : 385.
76. Tripathy SK, Keyel PA, Yang L, Pingel JT, Cheng TP, Schneeberger A et al. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J Exp Med 2008 205 : 1829 1841.
77. Sun JC, Lanier LL. Tolerance of NK cells encountering their viral ligand during development. J Exp Med 2008 205 : 1819 1828.
78. Tjwa ET, Van Oord GW, Hegmans JP, Janssen HLA, Woltam AM. Viral load reduction improves activation and function of natural killer cells in patients with chronic hepatitis B. J Hepatol 2010 (in press).
79. Dessouki O, Kamiya Y, Nagahama H, Tanaka M, Suzu S, Sasaki Y et al. Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: Reversion by anti-viral treatment. Biochem Biophys Res Commun 2010 393 : 331 337.
80. Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009 461 : 798 801.
81. Yamagiwa S, Matsuda Y, Ichida T, Honda Y, Takamura M, Sugahara S et al. Sustained response to interferon-alpha plus ribavirin therapy for chronic hepatitis C is closely associated with increased dynamism of intrahepatic natural killer and natural killer T cells. Hepatol Res 2008 38 : 664 672.
82. Nattermann J, Nischalke HD, Hofmeister V, Ahlenstiel G, Zimmermann H, Leifeld L et al. The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells. Am J Pathol 2005 166 : 443 453.
83. Kawarabayashi N, Seki S, Hatsuse K, Ohkawa T, Koike Y, Aihara T et al. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 2000 32 : 962 969.
84. Zou Y, Chen T, Han M, Wang H, Yan W, Song G et al. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol 2010 184 : 466 475.
85. Zou Z, Xu D, Li B, Xin S, Zhang Z, Huang L et al. Compartmentalization and its implication for peripheral immunologically-competent cells to the liver in patients with HBV-related acute-on-chronic liver failure. Hepatol Res 2009 39 : 1198 1207.
86. Yan MX, Mao HT, Liu Q, Wang WQ, Li YQ. Elevated levels of serum soluble E-selectin in patients with chronic hepatitis B: Correlation with T lymphocyte subsets, NK cells and liver inflammation. Hepatol Res 2006 35 : 111 117.
87. Sprengers D, van der Molen RG, Kusters JG, Hansen B, Niesters HG, Schalm SW et al. Different composition of intrahepatic lymphocytes in the immune-tolerance and immune-clearance phase of chronic hepatitis B. J Med Virol 2006 78 : 561 568.
88. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol 2004 24 : 637 646.